• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

网络药理学和分子对接方法阐明六味地黄丸治疗糖尿病骨质疏松症的作用机制。

Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis.

机构信息

The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.

出版信息

J Orthop Surg Res. 2022 Jun 14;17(1):314. doi: 10.1186/s13018-022-03194-2.

DOI:10.1186/s13018-022-03194-2
PMID:35701780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9195436/
Abstract

BACKGROUND

Diabetic osteoporosis (DOP) is one of the chronic complications of diabetes mellitus, but without a standardized treatment plan till now. Liuwei Dihuang pill (LDP) has gradually exerted a remarkable effect on DOP in recent years; its specific mechanism is not clear yet.

METHODS

We adopted network pharmacology approaches, including multi-database search, pharmacokinetic screening, network construction analysis, gene ontology enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis and molecular docking to elaborate the active components, signaling pathways and potential mechanisms of LDP in the treatment of DOP.

RESULTS

Twenty-seven active ingredients and 55 related disease targets have been found through integrated network pharmacology. Functional enrichment analysis shows that five key active ingredients, including beta-sitosterol, stigmasterol, diosgenin, tetrahydroalstonine, and kadsurenone, may give full scope to insulin secretion estrogen-level raising and angiogenesis in biological process through the pivotal targets. In addition, the underlying effect of PI3K/AKT/FOXO and VEGF pathways is also suggested in the treatment.

CONCLUSION

Based on systematic network pharmacology methods, we predicted the basic pharmacological effects and potential mechanisms of LDP in the treatment of DOP, revealing that LDP may treat DOP through multiple targets and multiple signaling pathways, which provide evidence for the further study of pharmacological mechanism and broader clinical thinking.

摘要

背景

糖尿病性骨质疏松症(DOP)是糖尿病的慢性并发症之一,但目前尚无标准化的治疗方案。近年来,六味地黄丸(LDP)在治疗 DOP 方面逐渐显现出显著效果,但其具体机制尚不清楚。

方法

我们采用网络药理学方法,包括多数据库检索、药代动力学筛选、网络构建分析、基因本体富集分析、京都基因与基因组百科全书通路分析和分子对接,阐述 LDP 治疗 DOP 的活性成分、信号通路和潜在机制。

结果

通过整合网络药理学,发现了 27 个活性成分和 55 个相关疾病靶点。功能富集分析表明,五种关键活性成分,包括β-谷甾醇、豆甾醇、薯蓣皂苷元、四氢巴马汀和川陈皮素,可能通过关键靶点在生物过程中充分发挥胰岛素分泌、雌激素水平升高和血管生成的作用。此外,还提示了 PI3K/AKT/FOXO 和 VEGF 通路的潜在作用。

结论

基于系统的网络药理学方法,我们预测了 LDP 治疗 DOP 的基本药理作用和潜在机制,表明 LDP 可能通过多种靶点和多种信号通路治疗 DOP,为进一步研究药理机制和更广泛的临床思维提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/3bbf499cef10/13018_2022_3194_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/55dc14efb5ae/13018_2022_3194_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/bbf0888af7b0/13018_2022_3194_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/3ca9832e016c/13018_2022_3194_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/9270ca269491/13018_2022_3194_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/bb016128a10b/13018_2022_3194_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/3bbf499cef10/13018_2022_3194_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/55dc14efb5ae/13018_2022_3194_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/bbf0888af7b0/13018_2022_3194_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/3ca9832e016c/13018_2022_3194_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/9270ca269491/13018_2022_3194_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/bb016128a10b/13018_2022_3194_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5209/9195436/3bbf499cef10/13018_2022_3194_Fig6_HTML.jpg

相似文献

1
Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis.网络药理学和分子对接方法阐明六味地黄丸治疗糖尿病骨质疏松症的作用机制。
J Orthop Surg Res. 2022 Jun 14;17(1):314. doi: 10.1186/s13018-022-03194-2.
2
Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus.基于网络药理学和分子对接预测方法,探讨六味地黄丸治疗耳鸣的潜在作用机制。
Medicine (Baltimore). 2022 Nov 18;101(46):e31711. doi: 10.1097/MD.0000000000031711.
3
A network pharmacological-based study of the mechanism of Liuwei Dihuang pill in the treatment of chronic kidney disease.基于网络药理学的六味地黄丸治疗慢性肾脏病作用机制研究。
Medicine (Baltimore). 2023 May 12;102(19):e33727. doi: 10.1097/MD.0000000000033727.
4
Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.基于加权基因共表达网络和网络药理学分析揭示六味地黄丸治疗糖尿病肾病相关骨质疏松症的关键 miRNAs 和靶点。
Endocr Metab Immune Disord Drug Targets. 2022;22(3):274-289. doi: 10.2174/1871530321666210215161921.
5
Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis.基于网络药理学的策略探讨六味地黄丸治疗绝经后骨质疏松症的药理机制。
Medicine (Baltimore). 2022 Nov 25;101(47):e31387. doi: 10.1097/MD.0000000000031387.
6
A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.一种基于网络药理学的策略,用于预测六味地黄丸治疗2型糖尿病的活性成分和潜在靶点。
Drug Des Devel Ther. 2019 Nov 28;13:3989-4005. doi: 10.2147/DDDT.S216644. eCollection 2019.
7
Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology.基于网络药理学的六味地黄丸治疗骨质疏松症的机制。
Medicine (Baltimore). 2023 Oct 20;102(42):e34773. doi: 10.1097/MD.0000000000034773.
8
Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接技术探究黄精治疗骨质疏松症的分子机制。
Front Endocrinol (Lausanne). 2022 Jan 5;12:815891. doi: 10.3389/fendo.2021.815891. eCollection 2021.
9
Exploring the pharmacological mechanism of Xianlingubao against diabetic osteoporosis based on network pharmacology and molecular docking: An observational study.基于网络药理学和分子对接技术探究仙灵骨葆治疗糖尿病性骨质疏松症的药理机制:一项观察性研究。
Medicine (Baltimore). 2024 Aug 2;103(31):e39138. doi: 10.1097/MD.0000000000039138.
10
Study on the mechanism of Qiju Dihuang pill in the treatment of ophthalmic diseases based on systems pharmacology.基于系统药理学研究杞菊地黄丸治疗眼病的作用机制。
Medicine (Baltimore). 2022 Aug 5;101(31):e30033. doi: 10.1097/MD.0000000000030033.

引用本文的文献

1
Drug repurposing in traditional Chinese medicine: from empirical wisdom to modern therapeutic strategies.中药中的药物重新利用:从经验智慧到现代治疗策略。
Front Pharmacol. 2025 Jul 31;16:1631727. doi: 10.3389/fphar.2025.1631727. eCollection 2025.
2
Network Pharmacology and In Vivo Evaluation of Lycium barbarum Polysaccharide in Preventing Perfluorooctanoic Acid-Induced Damage in Broilers.枸杞多糖预防全氟辛酸诱导的肉鸡损伤的网络药理学及体内评价
Poult Sci. 2025 Jul 3;104(10):105522. doi: 10.1016/j.psj.2025.105522.
3
Exploring the molecular mechanism of Si-Miao-Yong-An Decoction in treating diabetic foot using network pharmacological analysis and molecular docking technique.

本文引用的文献

1
The efficacy and safety of yukmijihwang-hwan (Liuweidihuang-wan) for type 2 diabetes mellitus without complications: A protocol for systematic review and meta-analysis.用于 2 型糖尿病非并发症患者的育阴降糖丸(六味地黄丸)的疗效和安全性:系统评价和荟萃分析的方案。
Medicine (Baltimore). 2022 Mar 18;101(11). doi: 10.1097/MD.0000000000029087.
2
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.ADMETlab 2.0:一个集成的在线平台,用于准确全面地预测 ADMET 性质。
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14. doi: 10.1093/nar/gkab255.
3
Dexamethasone suppresses osteogenesis of osteoblast the PI3K/Akt signaling pathway and .
运用网络药理学分析和分子对接技术探索四妙勇安汤治疗糖尿病足的分子机制。
Medicine (Baltimore). 2025 May 30;104(22):e42629. doi: 10.1097/MD.0000000000042629.
4
Anti-osteoporotic effect of sitagliptin in an osteoporosis model of ovariectomized rats: role of RUNX2 and RANKL/OPG ratio.西他列汀对去卵巢大鼠骨质疏松模型的抗骨质疏松作用:RUNX2及RANKL/OPG比值的作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 21. doi: 10.1007/s00210-025-04145-4.
5
Exploration of Liuwei Dihuang Pill on periodontitis based on network pharmacology and molecular docking.基于网络药理学和分子对接技术探讨六味地黄丸治疗牙周炎的作用机制
Medicine (Baltimore). 2025 May 16;104(20):e42466. doi: 10.1097/MD.0000000000042466.
6
Revealing the Potential of Solamargine for Anti Metastasis and Angiogenesis Inhibition in Nasopharyngeal Carcinoma.揭示冬凌草甲素在鼻咽癌抗转移和抑制血管生成方面的潜力。
J Inflamm Res. 2025 Apr 8;18:4879-4898. doi: 10.2147/JIR.S485244. eCollection 2025.
7
Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway.淫羊藿通过调节AGE-RAGE信号通路减轻糖尿病性骨质疏松症。
Mol Med. 2025 Mar 15;31(1):101. doi: 10.1186/s10020-025-01152-2.
8
A Systematic Review of the Phytochemical Profile and Potential Medicinal Functions of in Cancer.关于[具体植物名称未给出]在癌症中的植物化学特征和潜在药用功能的系统综述。
Food Sci Nutr. 2025 Feb 24;13(3):e70054. doi: 10.1002/fsn3.70054. eCollection 2025 Mar.
9
Network Pharmacology and Experimental Validation of the Therapeutic Effect of Baji Capsule on LPS-Induced Osteoporosis.八极胶囊对脂多糖诱导的骨质疏松症治疗作用的网络药理学及实验验证
Orthop Res Rev. 2025 Feb 11;17:61-81. doi: 10.2147/ORR.S488478. eCollection 2025.
10
Using network pharmacology and molecular docking technology, proteomics and experiments were used to verify the effect of Yigu decoction (YGD) on the expression of key genes in osteoporotic mice.运用网络药理学和分子对接技术,并通过蛋白质组学和实验来验证益骨汤(YGD)对骨质疏松小鼠关键基因表达的影响。
Ann Med. 2025 Dec;57(1):2449225. doi: 10.1080/07853890.2024.2449225. Epub 2025 Jan 3.
地塞米松抑制成骨细胞的成骨作用、PI3K/Akt信号通路以及……(原文此处不完整)
J Recept Signal Transduct Res. 2019 Feb;39(1):80-86. doi: 10.1080/10799893.2019.1625061. Epub 2019 Jun 18.
4
An update on therapies for the treatment of diabetes-induced osteoporosis.糖尿病性骨质疏松症治疗方法的最新进展。
Expert Opin Biol Ther. 2019 Sep;19(9):937-948. doi: 10.1080/14712598.2019.1618266. Epub 2019 May 27.
5
Insulin/IGF-1R, SIRT1, and FOXOs Pathways-An Intriguing Interaction Platform for Bone and Osteosarcoma.胰岛素/胰岛素样生长因子-1受体、沉默调节蛋白1和叉头框蛋白O通路——骨与骨肉瘤的一个有趣的相互作用平台
Front Endocrinol (Lausanne). 2019 Mar 1;10:93. doi: 10.3389/fendo.2019.00093. eCollection 2019.
6
Characteristics of the traditional Liu-Wei-Di-Huang prescription reassessed in modern pharmacology.在现代药理学中重新评估传统六味地黄方的特点。
Chin J Nat Med. 2019 Feb;17(2):103-121. doi: 10.1016/S1875-5364(19)30013-5.
7
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
8
Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.通过综合生物信息学分析鉴定与非小细胞肺癌发病机制和预后相关的候选生物标志物
Front Genet. 2018 Oct 12;9:469. doi: 10.3389/fgene.2018.00469. eCollection 2018.
9
The PI3K/AKT pathway in obesity and type 2 diabetes.肥胖和 2 型糖尿病中的 PI3K/AKT 通路。
Int J Biol Sci. 2018 Aug 6;14(11):1483-1496. doi: 10.7150/ijbs.27173. eCollection 2018.
10
ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.ADMETlab:一个基于全面收集的ADMET数据库进行系统性ADMET评估的平台。
J Cheminform. 2018 Jun 26;10(1):29. doi: 10.1186/s13321-018-0283-x.